ATE232724T1 - Inhibitor von stickstoffmonoxid (no) synthase zur verhütung von typ ii diabetes - Google Patents

Inhibitor von stickstoffmonoxid (no) synthase zur verhütung von typ ii diabetes

Info

Publication number
ATE232724T1
ATE232724T1 AT96944077T AT96944077T ATE232724T1 AT E232724 T1 ATE232724 T1 AT E232724T1 AT 96944077 T AT96944077 T AT 96944077T AT 96944077 T AT96944077 T AT 96944077T AT E232724 T1 ATE232724 T1 AT E232724T1
Authority
AT
Austria
Prior art keywords
diabetes
synthase
inhibitor
nitrogen monoxide
preventing type
Prior art date
Application number
AT96944077T
Other languages
English (en)
Inventor
Nicholas Charles Turner
Valerie Piercy
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of ATE232724T1 publication Critical patent/ATE232724T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
AT96944077T 1995-12-22 1996-12-18 Inhibitor von stickstoffmonoxid (no) synthase zur verhütung von typ ii diabetes ATE232724T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9526331.5A GB9526331D0 (en) 1995-12-22 1995-12-22 Novel method
PCT/EP1996/005871 WO1997023204A1 (en) 1995-12-22 1996-12-18 Nitric oxide (no) synthase inhibitor to treat or prevent type ii diabetes

Publications (1)

Publication Number Publication Date
ATE232724T1 true ATE232724T1 (de) 2003-03-15

Family

ID=10785930

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96944077T ATE232724T1 (de) 1995-12-22 1996-12-18 Inhibitor von stickstoffmonoxid (no) synthase zur verhütung von typ ii diabetes

Country Status (20)

Country Link
EP (1) EP0868175B1 (de)
JP (1) JP2000502668A (de)
KR (1) KR19990076595A (de)
CN (1) CN1209057A (de)
AT (1) ATE232724T1 (de)
AU (1) AU1379497A (de)
BR (1) BR9612245A (de)
CA (1) CA2240396A1 (de)
CZ (1) CZ198698A3 (de)
DE (1) DE69626307T2 (de)
ES (1) ES2193285T3 (de)
GB (1) GB9526331D0 (de)
HU (1) HUP9903979A3 (de)
IL (1) IL124870A0 (de)
MX (1) MX9805098A (de)
NO (1) NO982854L (de)
NZ (1) NZ325307A (de)
PL (1) PL327472A1 (de)
TR (1) TR199801133T2 (de)
WO (1) WO1997023204A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2893199A (en) * 1998-03-03 1999-09-20 Board Of Regents, The University Of Texas System Fatty acid-induced beta-cell apoptosis
CN1660428B (zh) * 2005-01-10 2011-09-07 王振军 一氧化氮合酶(nos)抑制剂用于治疗痔的新用途
ES2386831B1 (es) * 2011-02-04 2013-07-08 Servicio Andaluz De Salud Uso de inhibidores de la actividad de las NO sintasas (NOS) y sus composiciones, en la elaboración de un medicamento para el tratamiento y la prevención de la prediabetes y la diabetes mellitus tipo 1 (DM1)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE793646T1 (de) * 1994-11-23 1999-12-30 Upjohn Co Carboxylierte aminoguanidine zum behandlung von insulin-unabhängigem diabetes mellitus

Also Published As

Publication number Publication date
GB9526331D0 (en) 1996-02-21
BR9612245A (pt) 1999-07-13
PL327472A1 (en) 1998-12-07
CA2240396A1 (en) 1997-07-03
EP0868175B1 (de) 2003-02-19
NO982854D0 (no) 1998-06-19
NO982854L (no) 1998-06-19
DE69626307T2 (de) 2003-10-16
HUP9903979A2 (hu) 2000-03-28
CZ198698A3 (cs) 1999-06-16
WO1997023204A1 (en) 1997-07-03
TR199801133T2 (xx) 1998-09-21
KR19990076595A (ko) 1999-10-15
NZ325307A (en) 1999-11-29
AU1379497A (en) 1997-07-17
JP2000502668A (ja) 2000-03-07
ES2193285T3 (es) 2003-11-01
IL124870A0 (en) 1999-01-26
EP0868175A1 (de) 1998-10-07
CN1209057A (zh) 1999-02-24
MX9805098A (es) 1998-10-31
DE69626307D1 (de) 2003-03-27
HUP9903979A3 (en) 2000-05-29

Similar Documents

Publication Publication Date Title
BR9811099A (pt) Inibidores de urocinase
BG102259A (en) Compostions with controlled paroxetine release
TR199802676A2 (xx) T�m�rlerin, t�m�rle ilgili hastal�klar�n ve ka�eksinin tedavisi ve �nlenmesi i�in y�ntem.
DK0840606T3 (da) Små di- og trivalente molekyler som selectininhibitorer
DE69725860D1 (de) PLAN ZUR VERABREICHUNG VON H+, K+-ATPase INHIBITOREN
MX9800408A (es) Sales de derivados de amidina y de inhibidor de ciclooxigenasa, su procedimiento de preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen.
ATE241347T1 (de) Mercapto- und seleno-derivate als inhibitoren von stickstoffmonoxid-synthase
ATE232724T1 (de) Inhibitor von stickstoffmonoxid (no) synthase zur verhütung von typ ii diabetes
DK0821588T3 (da) Levobupivacain og anvendelse heraf som et anæstetikum til gravide kvinder
WO2001087239A3 (en) Methods of affecting laminin 5 processing
ES2193105T3 (es) Caramelos duros de estabilidad mejorada al almacenaje.
ATE159511T1 (de) Derivate von n,n,n',n'-tetrasubstituierten 1,2- ethylendiamin-verbindungen
EP0506716A4 (en) Method for the treatment of thrombocytopenia and pharmaceutical compositions useful therefor
ATE270113T1 (de) Zusammenstellungen zur verbesserten wundheilung
DE69637209D1 (de) Aminoguanidine zur behandlung von diabetes typ ii
ATE397615T1 (de) 6-o-alkyl-2-nor-2-substituierte ketolidderivate
PT971714E (pt) Metodo utilizando inibidores ciclooxigenase-2 no tratamento e prevencao da demencia
MX9701532A (es) Procedimiento para aumentar los niveles de testosterona.
UA34199A (uk) Спосіб лікування пародонтиту

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties